The overall message is that GLP-1RAs do appear to be multiuse, or pleiotropic to use the technical term
The makers of blockbuster GLP-1 drugs, Novo and Lilly, have long complained the U.S
The aforementioned two agents are currently undergoing preclinical investigations exclusively, with a specific focus on the NVU, exhibiting substantial therapeutic potential as neuroprotective agents
Proven efficacy: Effective in helping with weight loss and managing blood sugar levels in people with type 2 diabetes
After a month, looking back over those notes often reveals a clear upward trend that you would not have noticed in the moment
If patients score high enough on a widespread pain index, then that would be diagnostic of fibromyalgia, she says